| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.27B | 23.83B | 17.46B | 20.78B | 23.60B | 18.52B |
| Gross Profit | 9.87B | 9.35B | 5.24B | 7.39B | 8.97B | 6.47B |
| EBITDA | 5.92B | 5.86B | 2.11B | 4.60B | 6.14B | 3.53B |
| Net Income | 3.57B | 3.45B | 622.00M | 2.61B | 3.80B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 37.80B | 39.86B | 34.77B | 32.69B | 32.99B | 25.58B |
| Cash, Cash Equivalents and Short-Term Investments | 13.71B | 12.19B | 14.25B | 12.81B | 11.82B | 6.66B |
| Total Debt | 5.50B | 5.88B | 5.66B | 4.18B | 5.19B | 6.46B |
| Total Liabilities | 9.75B | 11.94B | 10.10B | 8.45B | 11.20B | 10.17B |
| Stockholders Equity | 28.05B | 27.91B | 24.67B | 24.24B | 21.79B | 15.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.66B | 397.00M | 2.43B | 3.89B | 19.00M |
| Operating Cash Flow | 0.00 | 1.80B | 2.31B | 3.35B | 4.81B | 1.42B |
| Investing Cash Flow | 0.00 | -3.58B | -2.20B | -849.00M | -562.00M | -1.50B |
| Financing Cash Flow | 0.00 | -514.00M | 879.00M | -1.58B | 947.00M | 2.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥51.45B | 9.91 | ― | 2.88% | 10.24% | 61.61% | |
79 Outperform | ¥54.90B | 15.34 | ― | 1.38% | 32.53% | 182.70% | |
77 Outperform | ¥52.95B | 17.75 | ― | 2.00% | -0.46% | -25.32% | |
66 Neutral | ¥32.24B | 11.61 | ― | 3.13% | 7.09% | 13.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥142.54B | 3.27 | ― | ― | -58.24% | ― | |
45 Neutral | ¥17.86B | -7.46 | ― | 3.46% | -7.92% | 43.84% |